- Home
- EML vs CADL Comparison
EML vs CADL Comparison
Compare EML & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- CADL
- Stock Information
- Founded
- EML 1858
- CADL 1999
- Country
- EML United States
- CADL United States
- Employees
- EML N/A
- CADL N/A
- Industry
- EML Industrial Machinery/Components
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- CADL Health Care
- Exchange
- EML Nasdaq
- CADL Nasdaq
- Market Cap
- EML 191.3M
- CADL 159.1M
- IPO Year
- EML N/A
- CADL 2021
- Fundamental
- Price
- EML $27.77
- CADL $8.75
- Analyst Decision
- EML
- CADL Strong Buy
- Analyst Count
- EML 0
- CADL 1
- Target Price
- EML N/A
- CADL $19.00
- AVG Volume (30 Days)
- EML 16.7K
- CADL 9.7M
- Earning Date
- EML 11-01-2024
- CADL 11-14-2024
- Dividend Yield
- EML 1.59%
- CADL N/A
- EPS Growth
- EML N/A
- CADL N/A
- EPS
- EML N/A
- CADL N/A
- Revenue
- EML $284,461,286.00
- CADL N/A
- Revenue This Year
- EML N/A
- CADL N/A
- Revenue Next Year
- EML N/A
- CADL N/A
- P/E Ratio
- EML $13.74
- CADL N/A
- Revenue Growth
- EML 7.70
- CADL N/A
- 52 Week Low
- EML $20.50
- CADL $1.08
- 52 Week High
- EML $35.78
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EML 40.52
- CADL 68.05
- Support Level
- EML $28.21
- CADL $5.90
- Resistance Level
- EML $30.72
- CADL $7.28
- Average True Range (ATR)
- EML 1.10
- CADL 1.61
- MACD
- EML -0.08
- CADL 0.37
- Stochastic Oscillator
- EML 0.00
- CADL 55.04
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.